Navigation Links
Does artificial intelligence help clinicians to recognize atrophic gastritis with thyroid disease?
Date:2/27/2008

The association of ABG with thyroid disorders (TD) was first described about 40 years ago. These older studies assessed the association between Pernicious Anemia (PA) and Thyroiditis on the basis of gastric and or thyroid auto-antibodies. Only recently systematic studies have focused on this frequently overlooked association.

A research article to be published on January 28, 2008 in the World Journal of Gastroenterology investigates the overlooked association. A study was performed on the data set of 29 input variables (concerning anagraphical, life style, family and clinical history, biochemical and histological aspects) of 253 ABG patients.

The biochemical and ultrasonographic data on the diagnosis of TD were not included in the data set. Of these ABG patients, 185 were female (median age 54 [17-83] years) and 123 had pernicious anemia. TD was present in 135 patients (53.4%), and 118 (46.6%) had a healthy thyroid gland. In all the patients the presence or absence of TD was evaluated by biochemistry, ultrasonography and endocrinological evaluation at a single tertiary centre, and its presence or absence was considered as target variable.

The sample of ABG patients was randomly subdivided several times in two equal and balanced samples of subjects with and without TD; one for the training phase (testing) and one for the prediction phase (testing).

To reduce the number of input variables, selecting those most informative to predict the output, the T&T system, the IS system, as well as the TWIST protocol were used. T&T is a data resampling technique, based on an evolutionary algorithm developed by the Semeion Research Center, the Genetic Doping Algorithm (GenD). The IS system is an evolutionary wrapper system, also based on the GenD, able to reduce the amount of data, while conserving the largest amount of information available in the data set. In the TWIST protocol, the T&T and IS systems run in a parallel way to reach a situable
'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Herbal Water Creating Taste Sensation: Ayalas Herbal Water Has No Calories, No Preservatives and No Artificial Additives. Just All the Natural Benefits of Herbs!
2. Brain measurements could lead to better devices to move injured or artificial limbs
3. Wearable Artificial Kidney Passes Test
4. Artificial skin system can heal wounds
5. Significantly higher success rates with artificial insemination
6. Artificial sweeteners linked to weight gain
7. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
8. Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices
9. Turn Competitive Intelligence into a Competitive Edge
10. NDMA Launches Clinical Intelligence Platform
11. Cogon Systems Supports the Pensacola Bay Area Chamber of Commerce with the Strategic Health Intelligence Summit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...HOUSTON, Nov. 7 The Ame...Lisa James, Director of Health at the Family Viole...uished Service today at its semi-annual policy-mak...ce is the highest honor the AMA House of Delegates...p://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ...
(Date:11/7/2009)...HOUSTON, Nov. 7 Calling this a "de...n (AMA), the AMA President J. James Rohack, M.D., ...ians from all state and medical specialty societie...aking meeting, where health system reform will top.../cgi-bin/prnh/20081209/AMALOGO ) ,, "Over the...
(Date:11/7/2009)...WASHINGTON, Nov. 7 With..., antichoice extremists are holding the entire bil...ey are demanding that the bill go far beyond the s...ncorporated into the original bill. In an outrage...rly Saturday afternoon, antichoice Democrats are d...
(Date:11/7/2009)...WASHINGTON, Nov. 7 The ... of Representatives to vote for the Stupak-Ellswor... Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski...l law on abortion funding and conscience protectio...H.R. 3962)," they said. ,, The letter was signe...
(Date:11/7/2009)...GTON, Nov. 7 Americans United for Life Action end...tupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-S...al money from going to abortion in health care ref...nt and CEO Dr. Charmaine Yoest said, "Americans Un...Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith A...
Breaking Medicine News(10 mins):Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...The Procter & Gamble,Company (NYSE: PG ) ann...61,percent increase for the October - December qua...m the Folgers transaction completed during the,qua...es were three percent below the year-ago quarter a...
...wo-thirds of Americans classified by the governmen...rent economic environment making it even more diff...ed Dr. Olga Stevko, Clinical Hypnotherapist and MD...individual and group sessions. Dr. Olga and her pr...
...nt and Future Growth Opportunities in Transplant D...an Expansion Strategy - , , SAN DIEGO, Calif., Ja... pioneer and leader in nucleic acid diagnostics fo... rapidly growing molecular diagnostics company bas...
...or, rapid transport, and,artificial blood products...,soldiers during the wars in Iraq and Afghanistan....cal transit from battlefield to combat hospitals i...),could be a viable new option for physicians trea...
...ominate State Fiscal Landscape, AHCA/Alliance Urge...deral Medicaid Funds , , WASHINGTON, Jan. 29 W... for vulnerable populations increasing at an alarm...er that will better protect U.S. seniors, ongoing ...
... Varian Medical,Systems (NYSE: VAR ) today repor...56 per diluted share in the first quarter of fisca...erations of $0.46 per diluted share in the year-ag...,continuing operations in the year-ago quarter, fi...
Other Medicine News:Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 2Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 3Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 4Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 5Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 6Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 7Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 8Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 9Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 10Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 11Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 12Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 13Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 14Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 15Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 16Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 17Health News:Expert Hypnotherapist Dr. Olga Stevko Offers Clients Simple and Powerful Tools for Lasting Weight Loss; Dr. Olga Combines Hypnotherapy and NLP to Transform Clients' Limi 2Health News:Expert Hypnotherapist Dr. Olga Stevko Offers Clients Simple and Powerful Tools for Lasting Weight Loss; Dr. Olga Combines Hypnotherapy and NLP to Transform Clients' Limi 3Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 2Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 3Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 4Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 6Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 7Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 8Health News:Regional Anesthesia Eases Wounded Soldiers' Pain in Iraq and Afghanistan 2Health News:Regional Anesthesia Eases Wounded Soldiers' Pain in Iraq and Afghanistan 3Health News:Stimulus Bill Requires Modification in U.S. Senate to Better Protect Seniors' Ongoing Access to Quality Nursing Home Care 2Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 2Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 3Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 4Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 5Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 6Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 7
(Date:11/6/2009)...,, SAN DIEGO, Nov. 6 ...company focused on developing products for minimal...nnounced today the appointment of Michael J. Lambe... Officer, effective November 9, 2009. The Company... Team updates. ,, "Michael will be an excellent...
(Date:11/6/2009)...,, SAN DIEGO, Nov. 6 ...hnology company focused on the development of smal... cancer and human immunodeficiency virus (HIV), to...results for the third quarter and nine months ende...ewscom.com/cgi-bin/prnh/20091104/ARDEALOGO ) ,,...
(Date:11/6/2009)...,, SAN DIEGO, Nov. 6 NexBio Inc... for Disease Control and Prevention (CDC), St. Lou...nounced today the publication of two articles in t...ished studies suggest that DAS181 (Fludase ® ...eatment and prevention of the Pandemic Influenza A...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Government Stops Unlawful Social Security Suspensions 3B Agrees to Repay More Than Half a Billion in Back Benefits 54271 1Government Stops Unlawful Social Security Suspensions 3B Agrees to Repay More Than Half a Billion in Back Benefits 54271 2Schering Plough Announces Resolution of Litigations on U S Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX 28R 29 54268 1Schering Plough Announces Resolution of Litigations on U S Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX 28R 29 54268 2Schering Plough Announces Resolution of Litigations on U S Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX 28R 29 54268 33SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 13SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 23SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 33SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 43SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 53SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 63SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 73SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 83SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 93SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 103SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 113SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 123SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 133SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 143SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 153SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 163SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 173SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 183SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 193SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 203SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 213SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 223SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 233SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 243SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 25
Cypher Stent
PT2LS Guide Wire (light support)
Fort Floppy
Lieberman Wire Angled Speculum
Medicine Products: